Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | MKNK1 | Q9BUB5 | 6/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.31 |
| ▸ | BCL6 | P41182 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1552309 | 1.00 | KDM4E (0.38) | KDM4EGAAL3MBTL1HTTMAPK1 | |
| SCHEMBL5436950 | 1.00 | KDM4E (0.38) | KDM4EGAAL3MBTL1HTTMAPK1 | |
| SCHEMBL1552577 | 0.90 | KDM4E (0.44) | KDM4EGAAL3MBTL1HTTSMN1; SMN2 | |
| SCHEMBL1552576 | 0.90 | KDM4E (0.44) | KDM4EGAAL3MBTL1HTTSMN1; SMN2 | |
| SCHEMBL11960089 | 0.90 | KDM4E (0.44) | KDM4EGAAL3MBTL1HTTSMN1; SMN2 | |
| SCHEMBL11960149 | 0.84 | HDAC6 (0.33) | HDAC6BACE1BACE2 | |
| SCHEMBL11960097 | 0.84 | HDAC6 (0.33) | HDAC6BACE1BACE2 | |
| SCHEMBL1551809 | 0.81 | RAB9A (0.45) | KDM4EGAAL3MBTL1HTTSMN1; SMN2 | |
| SCHEMBL1552560 | 0.81 | SMN1; SMN2 (0.45) | KDM4EGAAL3MBTL1MAPK1SMN1; SMN2 | |
| SCHEMBL1552534 | 0.81 | SMN1; SMN2 (0.45) | KDM4EGAAL3MBTL1MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2012588-B1 | AQUEOUS SUSPENSION CONCENTRATE | BAYER CROPSCIENCE AG (DE) | 2011-04-27 | — | — | EP | disclosed |
| US-20100048400-A1 | HERBICIDE COMBINATION | BAYER CROPSCIENCE AG (DE) | 2010-02-25 | — | — | US | disclosed |
| EP-1958509-A1 | Herbicide combination | Bayer CropScience AG (DE) | 2008-08-20 | — | — | EP | disclosed |
| EP-1854355-A1 | Aqueous suspension concentrates | Bayer CropScience AG (DE) | 2007-11-14 | — | — | EP | disclosed |
| US-20070219095-A1 | AQUEOUS SUSPENSION CONCENTRATES | BAYER CROPSCIENCE GMBH (DE) | 2007-09-20 | — | — | US | disclosed |
| US-20070123424-A1 | AQUEOUS SUSPENSION CONCENTRATES | BAYER CROPSCIENCE GMBH (DE) | 2007-05-31 | — | — | US | disclosed |
| EP-1790227-A1 | Aqueous suspension-concentrates of 2,4-diamino-s-triazine herbicides | Bayer CropScience AG (DE) | 2007-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123424-A1 | AQUEOUS SUSPENSION CONCENTRATES | ASH2L, SPATS2L, AS3MT | KDM4E 1181/4885GAA 3343/4885L3MBTL1 4057/4885 |
| US-20070219095-A1 | AQUEOUS SUSPENSION CONCENTRATES | SLC43A1, AS3MT, SLC7A5 | KDM4E 2316/4885GAA 810/4885L3MBTL1 1828/4885 |
| US-20100048400-A1 | HERBICIDE COMBINATION | DDT, DRD1, DRD2 | KDM4E 4476/4885GAA 1848/4885L3MBTL1 300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.